Pyridines as FBPase inhibitors for treatment of diabetes
申请人:Hoffmann-LA Roche Inc.
公开号:US08163778B2
公开(公告)日:2012-04-24
Compounds of formula (I)
as well as pharmaceutically acceptable salts and esters thereof wherein the residues have the significance given in claim 1 and which can be used in the form of pharmaceutical compositions.